Medifast, Inc. (MED) Stock Analysis

Medifast is a cash-rich but structurally challenged turnaround bet, trying to convert a collapsing coach-led weight-loss franchise into a GLP-1-era metabolic health platform.

Overview

Medifast is a coach-led metabolic health and weight-management company built around OPTAVIA meal-replacement “Fuelings” and behavioral support. Its legacy direct-to-consumer model is under heavy pressure from GLP-1 drugs and rapid coach attrition. The company is repositioning through LifeMD-enabled clinical consultations, lab testing, prescription access, and GLP-1 nutrition support programs. The core investment story is a high-risk transformation from a declining direct-selling weight-loss model into a clinically integrated metabolic wellness platform.

Read the full Medifast, Inc. research report

Loading the interactive MED dashboard…